EcoDrugPlus

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSLOCG00000001172
Gene Symbol: MKNK2
3 Cross references
224 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSLOCG00000016186
Gene Symbol: MDM2
1 Cross references
282 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSLOCG00000015595
Gene Symbol: MET
3 Cross references
212 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSLOCG00000005213
Gene Symbol: MLST8
3 Cross references
202 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSLOCG00000002794
Gene Symbol: NQO1
1 Cross references
195 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSLOCG00000007209
Gene Symbol: NOX4
4 Cross references
151 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSLOCG00000015181
Gene Symbol: NPC1L1
2 Cross references
189 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSLOCG00000001975
Gene Symbol: LOC102685549
3 Cross references
180 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSLOCG00000016042
Gene Symbol: PIM3
3 Cross references
217 Possible Orthologues:

Ros Proto-Oncogene 1, Receptor Tyrosine Kinase

Ensembl ID : ENSLOCG00000017138
Gene Symbol: ROS1
1 Cross references
124 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSLOCG00000013974
Gene Symbol: RAF1
3 Cross references
221 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSLOCG00000001989
Gene Symbol: ROCK1
1 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).